A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

EuroIntervention 2016;12:449-455. DOI: 10.4244/EIJV12I4A78

Kasper Kyhl
Kasper Kyhl1,2*, MD; Jacob Lønborg1, MD, PhD; Niels Vejlstrup1, MD, PhD; Henning Kelbæk1, MD, DMSc; Steffen Helqvist1, MD, DMSc; Lene Holmvang1, MD, DMSc; Erik Jørgensen1, MD; Kari Saunamäki1, MD, DMSc; Hans Erik Bøtker3, MD, PhD, DMSc; Peter Clemmensen1, MD, DMSc; Lars Køber1, MD, PhD, DMSc; Marek Treiman2, MD, DMSc; Thomas Engstrøm1, MD, PhD, DMSc
1. Department of Cardiology, Rigshospitalet, Copenhagen, Denmark; 2. Department of Biomedical Sciences, Copenhagen University, Copenhagen, Denmark; 3. Department of Cardiology, Aarhus University Hospital, Skejby, Denmark

Aims: We aimed to assess the effect of exenatide treatment as an adjunct to primary percutaneous coronary intervention (PCI) on long-term clinical outcome.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

cardioprotectionclinical outcomeexenatidemyocardial infarctionpharmacological conditioning
Coronary interventionsSTEMIAdjunctive pharmacotherapy
Read next article
Impact of non-compliant balloons on long-term clinical outcomes in coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II registry

Latest news